Guardant Health (GH) Cash & Current Investments (2017 - 2026)

Guardant Health has disclosed Cash & Current Investments across 10 years of filings, most recently posting $1.1 billion for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $1.1 billion, up 57.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 57.86% YoY), and the FY2025 annual result was $1.2 billion, up 43.05% from the prior year.
• Cash & Current Investments came in at $1.1 billion for Q1 2026 at Guardant Health, down from $1.2 billion in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $1.2 billion in Q2 2023 to a low of $580.0 million in Q3 2025.
• The 5-year median for Cash & Current Investments is $958.0 million (2022), against an average of $951.8 million.
• Across the five-year window, Cash & Current Investments plunged 52.35% in 2022 and soared 57.86% in 2026, its largest moves.
• Guardant Health's Cash & Current Investments stood at $1.0 billion in 2022, then rose by 15.57% to $1.2 billion in 2023, then retreated by 28.12% to $840.0 million in 2024, then jumped by 43.05% to $1.2 billion in 2025, then slipped by 8.23% to $1.1 billion in 2026.
• The last three Cash & Current Investments figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $580.0 million (Q3 2025), per Business Quant data.